重编程瘤微环境在头部和部状细胞癌:治疗目标和创新
Bruno Špiljak1, Bojan Poposki2, Stjepanka Lešić3
1Department of Oral Medicine, University of Zagreb School of Dental Medicine, Zagreb, 10000, Croatia.
Oncology research
|November 3, 2025
概括
由于耐药性,头支状细胞癌 (HNSCC) 具有挑战性. 用新型疗法准瘤微环境 (TME) 为个性化HNSCC治疗提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 头部和部状细胞癌 (HNSCC) 呈现出侵略性行为,高复发率和治疗耐药性.
- 瘤微环境 (TME),包括免疫细胞,肌体成分,癌症相关纤维细胞 (CAF),细胞外基质 (ECM) 和细胞因子,显著影响瘤的进展.
研究的目的:
- 审查HNSCC中瘤性转变的机制.
- 探索针对TME克服抗性的新疗法.
- 在个性化HNSCC治疗中呈现TME调制的翻译视角.
主要方法:
- 对瘤发生变化的主要机制的审查.
- 检查免疫检查点破坏,CAF介导的治疗耐药性,缺氧位和代谢依赖性的检查.
- 对新型治疗方法的分析,包括免疫检查点抑制剂 (ICI),TME调制,CAF重编程,缺氧向和ECM重塑.
主要成果:
- 在HNSCC的进展和治疗耐药性方面,TME起着至关重要的作用.
- 针对TME组件的新疗法显示了克服抗性的潜力.
- 正在探索将TME向治疗与其他治疗方式相结合.
结论:
- 在HNSCC TME中识别可操作的分子标对于个性化治疗至关重要.
- 挑战包括TME异质性,缺乏预测生物标志物,以及转化差距.
- 未来的研究应该侧重于患者分层,优化组合治疗和成本效益分析.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


